TNNI3 and COVID-19: It was observed that cTnI levels above 0.04 ng/mL and up to 0.39 ng/mL were present in 67.7% of patients with severe COVID-19, compared to 18.5% of patients who presented values below 0.04 ng/mL in a hospital setting [24].